Form 4: Privia Health Group EVP David Mountcastle Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


EVP and Chief Financial Officer of Privia Health Group, David Mountcastle, reports the acquisition of restricted stock units and a change in beneficial ownership of common stock.

Summary

  • David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., filed a Form 4 on March 7, 2025.
  • The report details transactions from March 5, 2025, including the acquisition of 33,430 shares of common stock through restricted stock units and a change in the amount of common stock beneficially owned.
  • Mountcastle directly acquired 33,430 shares of common stock at $0.00 per share.
  • Following the transaction, Mountcastle directly owns 191,157 shares of common stock.
  • Mountcastle indirectly owns 8,695 shares through his spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of restricted stock units is a standard practice and indicates confidence in the company's future. There are no explicitly negative aspects in the filing.

Positives

  • The acquisition of restricted stock units aligns Mountcastle's interests with the long-term performance of Privia Health Group.
  • The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The vesting of the restricted stock units over the next three years suggests an expectation of continued service and contribution from the executive.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings and transactions of company insiders. This filing indicates standard equity-based compensation practices within the healthcare technology sector.

Comparison to Industry Standards

  • Equity compensation is a common practice among publicly traded companies to align executive interests with shareholder value.
  • Companies like Teladoc Health and Cerner (now Oracle Health) also utilize restricted stock units as part of their executive compensation packages.
  • The vesting schedule of three years is typical for restricted stock units, ensuring long-term commitment from the executive.

Stakeholder Impact

  • Shareholders may view the equity-based compensation as a positive sign, aligning management's interests with the company's performance.
  • Employees may see this as a standard practice for executive compensation.

Key Dates

DateDescription
03/05/2025Date of transaction: Acquisition of restricted stock units and change in beneficial ownership.
03/07/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.